Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,905,721
-
Share change
-
+1,070,295
-
Total reported value
-
$278,346,543
-
Put/Call ratio
-
85%
-
Price per share
-
$17.50
-
Number of holders
-
69
-
Value change
-
+$19,010,580
-
Number of buys
-
31
-
Number of sells
-
32
Institutional Holders of ADAMAS PHARMACEUTICALS INC - COM (ADMS) as of Q1 2017
As of 31 Mar 2017,
ADAMAS PHARMACEUTICALS INC - COM (ADMS) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,905,721 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, FMR LLC, BlackRock Inc., Brenner West Capital Advisors, LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., EMERALD MUTUAL FUND ADVISERS TRUST, ONTARIO TEACHERS PENSION PLAN BOARD, and EMERALD ADVISERS INC/PA.
This page lists
69
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.